BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20130310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20131103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20140309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20141102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20150308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20151101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20140602
DTEND;VALUE=DATE:20140604
DTSTAMP:20140531T180238Z
CREATED:20140531T144257Z
LAST-MODIFIED:20140531T180238Z
UID:7873-1401667200-1401839999@globalbiodefense.com
SUMMARY:MCMi Regulatory Science Symposium
DESCRIPTION:FDA’s Medical Countermeasures Initiative (MCMi) will host the annual MCMi Regulatory Science Symposium June 2-3\, 2014 at FDA Headquarters in Silver Springs\, Maryland. \nThe goals of the event are to exchange ideas on countermeasure development; highlight work on regulatory science as it applies to developing and advancing medical countermeasures; facilitate innovative directions; and inform stakeholders on related scientific progress and achievements. \nHighlighted topics include: \nAnimal Models\, Biomarkers & Correlates of Protection\nAdvancing Technologies for Product Characterization\nMassively parallel sequencing for monitoring genetic variability of seed viruses for influenza vaccine\nEvaluation of New Technology Multiplex Tests for Detection of Emerging and Blood Borne Pathogens\nChallenges of a pediatric product in stockpiling: Feasibility studies with a pediatric product of oseltamivir phosphate\nThe influence of device design in cleaning biological and chemical contaminants from reusable medical devices\nAnimal Model Development for Eczema Vaccinatum\, a Life-Threatening Smallpox Vaccine Complication\nRole of natural killer cells against influenza in presence of humanized monoclonal antibodies\nSystems pharmacology for assessing and understanding drug safety\nThe Pathogenesis and Management of Anthrax Sepsis and Septic Shock: Studies in Small and Large Animal Models\nNovel nanoparticle and microfluidics approaches for detection of viral pathogens in laboratory based and point-of-care settings\nEvaluation of New Technology Multiplex Tests for Detection of Emerging and Blood Borne Pathogens\nRapid and comprehensive detection of antimicrobial resistance in bacterial pathogens\nEnabling sequence-based technologies for microbial countermeasures and clinical diagnostics\nHandheld Automated Notification for Drugs and Immunizations (HANDI)\nThe BARDA Clinical Study Network’s Role in MCM Surveillance\nReal-time Application for Portable Interactive Devices\nHarnessing electronic medical records for MCM Surveillance \nPlease visit the FDA’s MCMi Regulatory Science Symposium website for more information. Follow symposium updates on Twitter by searching #FDARegSci\, and follow MCMi at @FDA_MCMi. \nThe event will also be webcast live and program materials made available. There is no charge for this meeting.
URL:https://globalbiodefense.com/event/mcmi-regulatory-science-symposium/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
END:VEVENT
END:VCALENDAR